News Daily News BRIGHT Published: Prolonged Bivalirudin Reduces Bleeding, Tames Early Stent Thrombosis in Primary PCI April 03, 2015
News Daily News DAPT Substudy: No Apparent Benefit of Long-term DAPT in BMS Patients Yael L. Maxwell March 24, 2015
News Conference News ACC 2015 MATRIX Provides Support for Radial Access, Mixed Results for Bivalirudin Todd Neale March 17, 2015
News Daily News ITALIC Published: No Benefit to Long-Term DAPT After Stenting Yael L. Maxwell March 10, 2015
News Daily News Registry Data Suggest Net Clinical Benefit From Pretreating STEMI Patients With Clopidogrel Todd Neale February 05, 2015
News Daily News Year in Review: Physicians Highlight the Most Important Interventional News of 2014 Todd Neale January 12, 2015
News Daily News Un Análisis Conjunto a Nivel del Paciente Avala el Uso de Bivalirudina en PCI Primarias Yael L. Maxwell January 12, 2015
News Daily News Patient-Level Pooled Analysis Supports Bivalirudin Use in Primary PCI Yael L. Maxwell January 12, 2015
News Features Despite New Findings, Optimal DAPT Duration Still Up in the Air Todd Neale December 10, 2014
News Daily News Un Meta Análisis Cuestiona la Estrategia Anticoagulante ‘Talla Única’ en Pacientes STEMI L.A. McKeown November 17, 2014
News Conference News AHA 2014 Registry: Newer P2Y12 Inhibitors Reduce Stent Thrombosis, Mortality Over Clopidogrel Yael L. Maxwell November 17, 2014
News Daily News Meta-analysis Questions One-Size-Fits-All Anticoagulant Strategy in STEMI Patients L.A. McKeown November 17, 2014
News Conference News AHA 2014 Extending Clopidogrel Past 1 Year Improves Outcomes in DES, But Not BMS Patients Yael L. Maxwell November 16, 2014
News Conference News AHA 2014 DAPT Study Shows Benefit of Long-Term Treatment After DES Implantation Yael L. Maxwell November 16, 2014
News Conference News AHA 2014 Long-Term Better than Short-Term Prasugrel After PES Stenting November 15, 2014
News Conference News AHA 2014 ITALIC Shows Noninferiority of 6-Month DAPT in Good Aspirin Responders Yael L. Maxwell November 15, 2014
News Conference News AHA 2014 ISAR-SAFE: Another Randomized Trial Finds 6 Months of DAPT as Good as 12 Months November 15, 2014